Navigation Links
Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
Date:7/29/2008

GeneXpert Infinity-48 is the World's First Fully-Automated Random Access

Molecular Diagnostic Testing System; On Display at AACC Meeting

SUNNYVALE, Calif., July 29 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today introduced its GeneXpert(R) Infinity-48 high-throughput system at the 2008 American Association for Clinical Chemistry Annual Meeting in Washington, D.C. The newest addition to Cepheid's GeneXpert family of molecular diagnostic testing systems delivers the world's first and only fully-automated random access system designed for management of the entire molecular testing workflow. After a sample is loaded into a GeneXpert cartridge, the Infinity-48 System does the rest -- sample in, answer out. The Infinity-48 manages the sample data, cartridge loading and unloading and reporting of test results.

"Cepheid's GeneXpert Infinity-48 System represents the pinnacle of molecular diagnostics automation today," said Cepheid CEO John Bishop. "With an expanding pipeline of on-demand tests in the Infectious Disease, Oncology, and Genetic Disease markets, the Infinity Series of Systems is positioned to become the platform of choice for high-throughput laboratories."

Cepheid's GeneXpert Infinity-48 System uses robotic cartridge handling, managed by Cepheid's Xpertise(TM) software package and full touch screen driven menu, to run up to 1,300 different molecular tests during any 24-hour period, depending upon test selection. With each of the system's 48 testing modules managed as an independent testing site, the Infinity-48 System can start test runs anytime samples are collected -- 24 hours a day, 365 days a year. Delivering true walk away ease-of-use, the Infinity-48 System is positioned to improve workflow while further accelerating time-to-result, enabling healthcare providers to make more informed patient management and treatment decisions.

The Infinity-48 System can be configured with 16, 24, 32, 40, or 48 modules. To han
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cepheid Reports Second Quarter Revenue of $42.1 Million
2. Cepheid to Webcast Analyst Event
3. Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
4. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
5. Cepheid Market Reach Extended with Licenses in Canada and Registrations in Mexico
6. Cepheid Signs Group Purchasing Contract with Novation, the Nations Largest Healthcare Contracting Organization
7. Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference
8. Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
9. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-Fi...announcedtheapprovalofallofits,"firstday"motionsby...e"BankruptcyCourt").deCODElastweekfiledavoluntaryp...nkruptcyCodewiththe,BankruptcyCourt. , Theord...inue,tooperateitsbusinessduringtheChapter11proceed...
(Date:11/24/2009)...,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstCal...alcompanyfocusedondevelopingandcommercializingnove...DiTonno,PresidentandChiefExecutiveOfficer,isschedu...onference,tobeheldDecember1-2,2009atTheNewYorkPala...enGhiglieri,ChiefFinancialOfficer,willbeavailablet...
(Date:11/24/2009)...,, SEATTLE,Nov.24/PRNewswire/--BlueMarbleEner...licDevelopmentAuthority(OPDA)wererecentlyawarded$2...izationBoard(CERB)inaprivate/publicpartnershiptoco...eryinLincolnCounty,WA. ,, "Thisinvestmentwillsi...ringover70greenjobstoLincolnCounty,"saidBlueMarble...
(Date:11/24/2009)...,, ,Primaryefficacyendpointhasbeenmetforpatien... , QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AE...ny"),aglobalbiopharmaceuticalcompanyfocusedonendoc...acydatafromaPhase2studywithitstargetedcytotoxicpep...ithadvancedorrecurrentendometrialcancer.Inapersona...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...y, OAK BROOK, Ill. and CARY, N.C., Oct. 9 The Un...e of academic medical centers and,their affiliated...nt,technology and services for academic and resear...ship to provide organizations participating in,UHC... robust, easy-to-use,procurement engine to streaml...
... Vice President of Pharmac...gesX, Inc.,(Nasdaq: NGSX ), a biopharmaceutical c... therapies, announced today the appointment of Sus...rs and Russell Kawahata, Ph.D. as,the Vice Preside...esident & Chief Executive Officer, commented, "I a...
...sdaq: ORCH ), a leading worldwide provider of ide...pointment of James F. Smith as Vice,President and ...ectly to,Thomas A. Bologna, Orchid Cellmark,s Pres... 57, brings to Orchid Cellmark more than 25 years ... in financial management,including internal contro...
Other Biology Technology:University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 3NeurogesX Expands Senior Management Team 2NeurogesX Expands Senior Management Team 3Orchid Cellmark Appoints James F. Smith Chief Financial Officer 2Orchid Cellmark Appoints James F. Smith Chief Financial Officer 3
(Date:11/23/2009)...he only swine vaccine available for the H1N1 virus...with the virus. The vaccination marks the first ti... with the pandemic flu., Iowa State University,s...ed the vaccine this summer and has been shipping p... and Illinois for several weeks., The latest vac...
(Date:11/23/2009)...ember 16, 2009 -- A USDOE and USDA study concluded...land, and cropland pasture could be converted from...es, such as switchgrass, from which biomass could ...mically viable production of a perennial grass mon...ass are removed annually is expected to require ni...
(Date:11/23/2009)...University of New Hampshire microbiologist Louis T...dvance understanding of the actinorhizal plants, w...trient-poor and contaminated soils. , The Unite...Tisa, a professor of molecular, cellular and biome...relationship between the bacteria Frankia and Casu...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Biotechnology Salutes Americas Veterans 3B Innovations Continue to Offer Improved Treatment and Care of Combat Troops 6171 1Biotechnology Salutes Americas Veterans 3B Innovations Continue to Offer Improved Treatment and Care of Combat Troops 6171 2CryoLife to Present at Upcoming Investor Conferences in New York 6166 1CryoLife to Present at Upcoming Investor Conferences in New York 6166 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 1Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 4
...University scientists to confirm that eagles from ...of birds. , By performing DNA analysis on the feat... were able to identify individual Eastern imperial...nalysis showed that not one adult strayed from its...birds, the vast majority of which mate with and ra...
...und evidence that the retina actively seeks novel ...justing its processing in order to seek the unusua...eport in this week,s issue of the journal Nature o...ection operates in many visual environments. , "Ap...itself," says Markus Meister, the Jeff C. Tarr Pro...
... on earth, there were organic molecules that combi...h were the first elements able to self-replicate. ...ese molecules were ribonucleic acid (RNA) chains, ...d that today has the secondary role in cells of co... into proteins. , These proteins have a direct act...
Other Biology News:DNA from feathers tells tale of eagle fidelity 2DNA from feathers tells tale of eagle fidelity 3Retina adapts to seek the unexpected, ignore the commonplace 2Life's origins were easier than was thought 2
...peptide derived from the C-terminal region catalyt...soform (PKCzeta). Specificity: Reacts with the ra...nd PKMzeta (PKCzeta II) and does not cross-react w...ve controls: mouse and rat kidney and brain homoge...
GIBCO AlbuMAX II from Invitrogen
GIBCO Dulbecco's Phosphate-Buffered Saline (D-PBS) (1X) liquid from Invitrogen
Rabbit Anti-LSD1 / BHC110 Antibody, Unconjugated from Upstate
Biology Products: